aluminum phthalocyanine has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, JY; Huang, X; Qin, YL | 1 |
| Lü, FD | 1 |
2 other study(ies) available for aluminum phthalocyanine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Conjugation of sulfonated aluminum phthalocyanine to doxorubicin can improve the efficacy of photodynamic cancer therapy.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Humans; Indoles; Leukemia, Basophilic, Acute; Liver Neoplasms; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Rats | 2012 |
[Experimental study of the photokilling effect of a new photosensitizer, aluminum phthalocyanine, on human hepatoma cell line].
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Humans; Indoles; Light; Liver Neoplasms; Organometallic Compounds; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1991 |